CERo Therapeutics Holdings, Inc.
CERO
$5.40
-$0.10-1.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.54% | -55.37% | -13.92% | -62.90% | -59.42% |
| Total Depreciation and Amortization | -2.49% | 1.13% | 4.13% | 39.77% | 108.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.09% | -109.08% | -4,727.20% | -99.24% | -52.39% |
| Change in Net Operating Assets | 516.10% | 359.85% | 240.17% | -77.91% | -114.85% |
| Cash from Operations | -22.68% | -30.19% | -123.07% | -137.14% | -168.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -107.41% | -104.49% |
| Total Debt Issued | -96.64% | -98.65% | -30.30% | -67.49% | -67.49% |
| Total Debt Repaid | -49.82% | -1,943.15% | -- | -576.46% | -- |
| Issuance of Common Stock | 77.39% | 37.13% | 97,206.25% | 121,241.56% | 87,838.96% |
| Repurchase of Common Stock | 88.95% | -264,726.32% | -264,726.32% | 96.75% | 96.75% |
| Issuance of Preferred Stock | -62.32% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4,055.47% | -1,182.04% | -1,182.04% | -141,863.16% | 133.25% |
| Cash from Financing | 33.58% | 66.90% | 2,301.22% | 108.86% | 107.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.00% | 135.72% | 115.55% | -100.26% | -102.97% |